Your browser doesn't support javascript.
loading
CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.
McWilliams, Robert R; Wieben, Eric D; Chaffee, Kari G; Antwi, Samuel O; Raskin, Leon; Olopade, Olufunmilayo I; Li, Donghui; Highsmith, W Edward; Colon-Otero, Gerardo; Khanna, Lauren G; Permuth, Jennifer B; Olson, Janet E; Frucht, Harold; Genkinger, Jeanine; Zheng, Wei; Blot, William J; Wu, Lang; Almada, Luciana L; Fernandez-Zapico, Martin E; Sicotte, Hugues; Pedersen, Katrina S; Petersen, Gloria M.
Afiliação
  • McWilliams RR; Department of Oncology, Mayo Clinic, Rochester, Minnesota. Mcwilliams.robert@mayo.edu.
  • Wieben ED; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
  • Chaffee KG; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Antwi SO; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Raskin L; Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida.
  • Olopade OI; Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Li D; Departments of Medicine and Human Genetics, University of Chicago Medical Center, Chicago, Illinois.
  • Highsmith WE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Colon-Otero G; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Khanna LG; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida.
  • Permuth JB; Department of Medicine, Columbia University Medical Center, New York, New York.
  • Olson JE; Departments of Cancer Epidemiology and Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Frucht H; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Genkinger J; Department of Medicine, Columbia University Medical Center, New York, New York.
  • Zheng W; Department of Epidemiology, Columbia University Medical Center, New York, New York.
  • Blot WJ; Herbert Irving Comprehensive Cancer Center, New York, New York.
  • Wu L; Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Almada LL; Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Fernandez-Zapico ME; Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Sicotte H; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota.
  • Pedersen KS; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota.
  • Petersen GM; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Cancer Epidemiol Biomarkers Prev ; 27(11): 1364-1370, 2018 11.
Article em En | MEDLINE | ID: mdl-30038052

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidor p16 de Quinase Dependente de Ciclina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidor p16 de Quinase Dependente de Ciclina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article